Olmesartan Medoxomil/Amlodipine Nicotinate

奥美沙坦酯/烟酸氨氯地平

Report date: 2022/01/14 13:23:58

Base Information

Drug NameOlmesartan Medoxomil/Amlodipine Nicotinate
Drug Alias NameLodivikar
ClassificationSmall molecules
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockers
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channel
Therapy Area/IndicationsHypertension
Global Approved IndicationsHypertension
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved Date2014/01/01
Country/TerritoryN/A
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesHanmi Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHypertension
Inactive IndicationsN/A

Other Information

ATC CodeC09DB02
Related LinksN/A